Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

35 results
Display

Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide

Ohe M, Hashino S

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Which treatment modality should we choose for advanced hepatocellular carcinoma?

Kim DY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Orbital Metastatic Angiosarcoma

Hassane S, Fouad E, Said I, Karim R, Asmae N, Houcine C, Abdelbar O

We report a case of a 48-year-old man who developed metastatic angiosarcoma in her left orbit. A 48-year-old man was first sent to us for a check up of proptosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Visual Prognosis of Retinoblastoma in the Posterior Pole Treated with Primary Chemotherapy Plus Local Treatments

Kim JM, Kim JH, Kim SJ, Park KD, Shin HY, Ahn HS, Yu YS

PURPOSE: To evaluate the visual outcomes of retinoblastoma in the posterior pole (RBPP) treated with chemotherapy plus local treatments and to address the prognostic factors that influence such outcomes. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of neural stem cells and 5-fluorocytosine in canine metastatic lung tumor

Hwang Y, Kim D, Chang D, Ahn B, Kim YB, Kim G

This is the first case report to describe the tumor regressive effect of systemic human neural stem cell (NSC)/5-fluorocytosine (5-FC) therapy on canine metastatic lung tumor. The therapeutic effects appeared...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic efficacy of nanomedicines for prostate cancer: An update

Lakshmanan VK

Recent advances in cancer nanomedicine have attracted remarkable attention in medical sectors. Pharmacologic research on nanomedicines, including targeted cancer therapy, has increased dramatically in the past 5 years. The success...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oromucosal Cytokine Therapy: Mechanism(s) of Action

Tovey MG

  • KMID: 1123161
  • Korean J Hepatol.
  • 2002 Jun;8(2):125-131.
Oromucosal cytokine therapy allows large amounts of cytokines to be administered with improved outcome and without dose limiting toxicity. Orally administered cytokines exert their effects by a novel two pronged...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma

Ji SK, Park NH, Choi HM, Kim YW, Lee SH, Lee KH, Ahn SY, Lee SU, Han BH, Park BC

  • KMID: 1038464
  • Korean J Intern Med.
  • 1996 Jan;11(1):58-68.
To evaluate the clinical efficacy of alpha-interferon(IFN-alpha) plus cis-platinum in hepatocellular carcinoma(HCC). 56 inoperable patients with HCC were divided into IFN-alpha plus cis-platinum treated group (n = 30) and no...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Change of telomerase activity in rectal cancer with chemoradiation therapy

Kim HR, Kim YJ, Kim HJ, Kim SK, Lee JH

Telomerase, an enzyme associated with cellular immortality, is expressed by most malignant cells and is inactive in most normal somatic cells, with the exception of proliferative stem cells, germ cells...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma

Seo MS, Kim JK, Shim JY

We report a case of regression of multiple pulmonary metastases, which originated from hepatocellular carcinoma after treatment with intravenous administration of high-dose vitamin C. A 74-year-old woman presented to the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phase II Study of Cyclophosphamide, Epirubicin, Vincristine, Prednisone, and Etoposide (CEOP-E) for Aggressive Non-Hodgkin 's Lymphoma

Kim JG, Sohn SK, Kim DH, Baek JH, Park TI, Lee KB

The main objectives of the current study were to evaluate the efficacy and safety of a CEOP-E regimen for patients with aggressive non-Hodgkin's lymphoma (NHL). Fifty-one consecutive patients with newly...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rapid Intra-Hepatic Dissemination of Hepatocellular Carcinoma with Pulmonary Metastases Following Combined Loco-Regional Therapy

Pua U

This manuscript describes an unusual case of rapid intra-hepatic dissemination of hepatocellular carcinoma with pulmonary metastases occurring 1 month after combined chemoembolization and radiofrequency ablation. Inferior vena cava and portal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Radiofrequency Ablation Combined with Chemoembolization for Intermediate-Sized (3-5 cm) Hepatocellular Carcinomas Under Dual Guidance of Biplane Fluoroscopy and Ultrasonography

Min JH, Lee MW, Cha DI, Jeon YH, Shin SW, Cho SK, Rhim H, Lim HK

OBJECTIVE: To assess the technical feasibility and local efficacy of percutaneous radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) for an intermediate-sized (3-5 cm in diameter) hepatocellular carcinoma (HCC)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical effect of abiraterone acetate in Korean patients with metastatic castration-resistant prostate cancer according to duration of androgen deprivation therapy

Kim KB, Jo JK, Ahn S, Lee S, Jeong SJ, Hong SK, Byun SS, Lee SE

PURPOSE: Few data are available concerning the clinical outcome of abiraterone acetate treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) in terms of the duration of androgen deprivation therapy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Right Hepatectomy in a Patient with Hepatocellular Carcinoma after Induction of Hepatic Parenchymal Atrophy through Subsequent Portal and Hepatic Vein Embolizations

Hwang S

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

Woo HY, Heo J

Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma

Cha J, Seong J, Lee IJ, Kim JW, Han KH

PURPOSE: Sorafenib is an effective systemic agent for advanced hepatocellular carcinoma. To increase its efficacy, we evaluated the feasibility and benefit of sorafenib combined with radiotherapy. MATERIALS AND METHODS: From July...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
ESHAP Salvage Therapy for Refractory and Relapsed Non-Hodgkins Lymphoma: A Single Center Experience

Park SH, Kim S, Ko OB, Koo JE, Lee D, Jeong YP, Huh J, Kim SB, Kim SW, Lee JL, Suh C

BACKGROUND: The ESHAP chemotherapy regimen, that is, the combination of the etoposide, methylprednisolone, high-dose cytarabine and cisplatin, has been shown to be active against relapsing or refractory non-Hodgkin's lymphoma...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gemcitabine, Etoposide, Cisplatin, and Dexamethasone in Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma

Kim KH, Joo YD, Sohn CH, Shin HJ, Chung JS, Cho GJ, Shin SH, Kim YS, Lee WS

BACKGROUND/AIMS: To date, an effective salvage chemotherapy regimen for the treatment of refractory or relapsing non-Hodgkin's lymphoma (NHL) has not been discovered. This study was conducted to evaluate the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma

Lee IJ, Kim JW, Han KH, Kim JK, Kim KS, Choi JS, Park YN, Seong J

PURPOSE: For locally unresectable hepatocellular carcinoma (HCC) patients, concurrent chemoradiotherapy (CCRT) has been applied as a loco-regional treatment. After shrinkage of tumors in selected patients, surgical resection is performed. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr